Adrian Rawcliffe is Chief Executive Officer of Adaptimmune Therapeutics PLC. Currently has a direct ownership of 44,848 shares of ADAP, which is worth approximately $42,605. The most recent transaction as insider was on Jan 17, 2024, when has been sold 30,080 shares (American Depositary Shares representing Ordinary Shares) at a price of $0.67 per share, resulting in proceeds of $20,153. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.8K
0% 3M change
1200.32% 12M change
Total Value Held $42,605

Adrian Rawcliffe Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 17 2024
SELL
Open market or private sale
$20,153 $0.67 p/Share
30,080 Reduced 40.15%
44,848 American Depositary Sh...
Jan 16 2024
SELL
Open market or private sale
$7,350 $0.79 p/Share
9,304 Reduced 39.75%
14,104 American Depositary Sh...
Jan 12 2024
SELL
Open market or private sale
$14,668 $0.85 p/Share
17,257 Reduced 39.54%
26,388 American Depositary Sh...
Jan 11 2024
SELL
Open market or private sale
$10,033 $0.84 p/Share
11,945 Reduced 39.37%
18,395 American Depositary Sh...
Sep 01 2023
SELL
Open market or private sale
$1,874 $0.78 p/Share
2,403 Reduced 41.06%
3,449 American Depositary Sh...
Jun 27 2023
SELL
Open market or private sale
$2,146 $0.92 p/Share
2,333 Reduced 39.87%
3,519 American Depositary Sh...
Jan 17 2023
SELL
Open market or private sale
$18,706 $1.86 p/Share
10,057 Reduced 42.96%
13,351 American Depositary Sh...
Jan 12 2023
SELL
Open market or private sale
$32,084 $1.71 p/Share
18,763 Reduced 42.99%
24,882 American Depositary Sh...
Jan 11 2023
SELL
Open market or private sale
$22,823 $1.75 p/Share
13,042 Reduced 42.99%
17,298 American Depositary Sh...
Jan 04 2023
SELL
Open market or private sale
$8,573 $1.69 p/Share
5,073 Reduced 43.34%
6,631 American Depositary Sh...
Sep 01 2022
SELL
Open market or private sale
$4,996 $1.97 p/Share
2,536 Reduced 43.34%
3,316 American Depositary Sh...
Jun 27 2022
SELL
Open market or private sale
$4,176 $1.63 p/Share
2,562 Reduced 43.78%
3,290 American Depositary Sh...
Jan 18 2022
SELL
Open market or private sale
$35,396 $3.19 p/Share
11,096 Reduced 47.4%
12,312 American Depositary Sh...
Jan 12 2022
SELL
Open market or private sale
$10,783 $3.54 p/Share
3,046 Reduced 47.58%
3,356 American Depositary Sh...
Jan 11 2022
SELL
Open market or private sale
$51,129 $3.56 p/Share
14,362 Reduced 47.34%
15,978 American Depositary Sh...
Jan 04 2022
SELL
Open market or private sale
$22,460 $4.06 p/Share
5,532 Reduced 47.27%
6,172 American Depositary Sh...
Sep 01 2021
SELL
Open market or private sale
$14,466 $5.2 p/Share
2,782 Reduced 47.54%
3,070 American Depositary Sh...
Jun 28 2021
SELL
Open market or private sale
$12,210 $4.37 p/Share
2,794 Reduced 47.74%
3,058 American Depositary Sh...
Jan 19 2021
SELL
Open market or private sale
$56,014 $5.67 p/Share
9,879 Reduced 42.2%
13,529 American Depositary Sh...
Jan 12 2021
SELL
Open market or private sale
$16,648 $6.15 p/Share
2,707 Reduced 42.28%
3,695 American Depositary Sh...
Jan 04 2021
SELL
Open market or private sale
$26,474 $5.33 p/Share
4,967 Reduced 42.44%
6,737 American Depositary Sh...

Also insider at

WVE
Wave Life Sciences Ltd. Healthcare
AR

Adrian Rawcliffe

Chief Executive Officer
Cambridge, MA

Track Institutional and Insider Activities on ADAP

Follow Adaptimmune Therapeutics PLC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADAP shares.

Notify only if

Insider Trading

Get notified when an Adaptimmune Therapeutics PLC insider buys or sells ADAP shares.

Notify only if

News

Receive news related to Adaptimmune Therapeutics PLC

Track Activities on ADAP